Construction of a Full Length Infectious Clone for Dengue-1 Virus Western Pacific,74 Strain

The flavivirus dengue 1 Western Pacific,74 (DEN1 WP) virus has a positive-stranded RNA genome of 10,735 nucleotides. DEN1 WP genomic RNA was amplified into three overlapping fragments by RT-PCR. These fragments were assembled into a full-length cDNA clone in the yeast-E. coli shuttle vector pRS424, using homologous recombination in yeast. RNA produced by in vitro transcription of this clone was infectious upon electroporation into LLCMK2 cells, as shown by cytopathic effects and detection of viral antigens by indirect immunofluorescence, and by propagation of the virus released into the culture media. Biological properties of the transcript-derived virus, such as the pattern of dengue-specific protein synthesis and growth rate in LLCMK2 or C6/36 cells, resembled those of the parent DEN1 WP virus.

[1]  A. Allison,et al.  Dengue viruses and mononuclear phagocytes. II. Identity of blood and tissue leukocytes supporting in vitro infection , 1977, The Journal of experimental medicine.

[2]  S. Halstead,et al.  Pathogenesis of dengue: challenges to molecular biology. , 1988, Science.

[3]  W. Brandt.  Development of dengue and Japanese encephalitis vaccines. , 1990 .

[4]  R. Padmanabhan,et al.  Synthesis and characterization of an infectious dengue virus type-2 RNA genome (New Guinea C strain). , 1995, Gene.

[5]  D. Vaughn,et al.  Testing of a dengue 2 live-attenuated vaccine (strain 16681 PDK 53) in ten American volunteers. , 1996, Vaccine.

[6]  W. Bancroft,et al.  Selection of attenuated dengue 4 viruses by serial passage in primary kidney cells. V. Human response to immunization with a candidate vaccine prepared in fetal rhesus lung cells. , 1984, The American journal of tropical medicine and hygiene.

[7]  W. Bancroft,et al.  Virulence of a live dengue virus vaccine candidate: a possible new marker of dengue virus attenuation. , 1988, The Journal of infectious diseases.

[8]  B. Falgout,et al.  Identification of Specific Nucleotide Sequences within the Conserved 3′-SL in the Dengue Type 2 Virus Genome Required for Replication , 1998, Journal of Virology.

[9]  J J Gestal Otero,et al.  [Emerging infectious diseases]. , 1997, Medicina clinica.

[10]  D. Vaughn,et al.  A live attenuated dengue-1 vaccine candidate (45AZ5) passaged in primary dog kidney cell culture is attenuated and immunogenic for humans. , 1994, The Journal of infectious diseases.

[11]  R. Wickner,et al.  Elimination of L-A double-stranded RNA virus of Saccharomyces cerevisiae by expression of gag and gag-pol from an L-A cDNA clone , 1993, Journal of virology.

[12]  J. Roehrig,et al.  Construction of infectious cDNA clones for dengue 2 virus: strain 16681 and its attenuated vaccine derivative, strain PDK-53. , 1997, Virology.

[13]  W. Brandt,et al.  Current Approaches to the Development of Dengue Vaccines and Related Aspects of the Molecular Biology of Flaviviruses , 1988 .

[14]  Robert H Levis,et al.  Infectious RNA transcripts from full-length dengue virus type 2 cDNA clones made in yeast , 1997, Journal of virology.

[15]  M. Dante,et al.  Multifunctional yeast high-copy-number shuttle vectors. , 1992, Gene.

[16]  W. Bancroft,et al.  Dengue virus type 2 vaccine: reactogenicity and immunogenicity in soldiers. , 1984, The Journal of infectious diseases.

[17]  K. Porter,et al.  Molecular analysis of dengue virus attenuation after serial passage in primary dog kidney cells. , 1997, The Journal of general virology.

[18]  S. Halstead,et al.  Antibody-enhanced dengue virus infection in primate leukocytes , 1977, Nature.

[19]  A. Davidson,et al.  Identification of a major determinant of mouse neurovirulence of dengue virus type 2 using stably cloned genomic-length cDNA. , 1998, The Journal of general virology.